Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kim

Showing results (1011-1020 of 1,050) with videos related to

Pageof 105
Sort By:
Thorax|February 2, 2018
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbationsDavid Mayhew, Nathalie Devos, Christophe Lambert, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2007
Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitorsBrian L Hodous, Stephanie D Geuns-Meyer, Paul E Hughes, et al.
Nature Communications|March 10, 2023
The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinomaLucia Morgado-Palacin, Jessie A Brown, Thomas F Martinez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter studyJean-Jacques Patard, Hyung L Kim, John S Lam, et al.
European Urology Focus|December 14, 2022
A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active SurveillanceJ Kellogg Parsons, Peter A Pinto, Christian P Pavlovich, et al.
Prostate Cancer and Prostatic Diseases|December 14, 2018
Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillanceHyung L Kim, Ping Li, Huei-Chung Huang, et al.
Science Translational Medicine|November 3, 2017
A precision therapy against cancers driven by <i>KIT/PDGFRA</i> mutationsErica K Evans, Alexandra K Gardino, Joseph L Kim, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Inhibitors of hepatitis C virus NS3.4A protease. Part 3: P2 proline variantsRobert B Perni, Luc J Farmer, Kevin M Cottrell, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2008
Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinaseVictor J Cee, Alan C Cheng, Karina Romero, et al.
Cancer|April 20, 2017
Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT studyJohn L Gore, Marguerite du Plessis, María Santiago-Jiménez, et al.
Pageof 105

Showing results (1011-1020 of 1,050) with videos related to

Sort By:
Pageof 105
Thorax|February 2, 2018
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbationsDavid Mayhew, Nathalie Devos, Christophe Lambert, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2007
Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitorsBrian L Hodous, Stephanie D Geuns-Meyer, Paul E Hughes, et al.
Nature Communications|March 10, 2023
The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinomaLucia Morgado-Palacin, Jessie A Brown, Thomas F Martinez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter studyJean-Jacques Patard, Hyung L Kim, John S Lam, et al.
European Urology Focus|December 14, 2022
A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active SurveillanceJ Kellogg Parsons, Peter A Pinto, Christian P Pavlovich, et al.
Prostate Cancer and Prostatic Diseases|December 14, 2018
Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillanceHyung L Kim, Ping Li, Huei-Chung Huang, et al.
Science Translational Medicine|November 3, 2017
A precision therapy against cancers driven by <i>KIT/PDGFRA</i> mutationsErica K Evans, Alexandra K Gardino, Joseph L Kim, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Inhibitors of hepatitis C virus NS3.4A protease. Part 3: P2 proline variantsRobert B Perni, Luc J Farmer, Kevin M Cottrell, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2008
Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinaseVictor J Cee, Alan C Cheng, Karina Romero, et al.
Cancer|April 20, 2017
Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT studyJohn L Gore, Marguerite du Plessis, María Santiago-Jiménez, et al.
Pageof 105